Targeting signalling pathways and the immune microenvironment of cancer stem cells—a clinical update

JA Clara, C Monge, Y Yang, N Takebe - Nature reviews clinical …, 2020 - nature.com
Cancer stem cells (CSCs) have important roles in tumour development, relapse and
metastasis; the intrinsic self-renewal characteristics and tumorigenic properties of these cells …

New insights into antiangiogenic therapy resistance in cancer: Mechanisms and therapeutic aspects

M Huang, Y Lin, C Wang, L Deng, M Chen… - Drug resistance …, 2022 - Elsevier
Angiogenesis is a hallmark of cancer and is required for tumor growth and progression.
Antiangiogenic therapy has been revolutionarily developing and was approved for the …

[HTML][HTML] Sunitinib resistance in renal cell carcinoma: From molecular mechanisms to predictive biomarkers

J Jin, Y Xie, JS Zhang, JQ Wang, SJ Dai, W He… - Drug Resistance …, 2023 - Elsevier
Currently, renal cell carcinoma (RCC) is the most prevalent type of kidney cancer. Targeted
therapy has replaced radiation therapy and chemotherapy as the main treatment option for …

Resistance to systemic therapies in clear cell renal cell carcinoma: mechanisms and management strategies

P Makhov, S Joshi, P Ghatalia, A Kutikov… - Molecular cancer …, 2018 - AACR
Renal cell carcinoma (RCC) is the most common form of kidney cancer. It is categorized into
various subtypes, with clear cell RCC (ccRCC) representing about 85% of all RCC tumors …

[HTML][HTML] Notch signaling: an emerging therapeutic target for cancer treatment

X Yuan, H Wu, H Xu, H Xiong, Q Chu, S Yu, GS Wu… - Cancer letters, 2015 - Elsevier
The Notch pathway is involved in cell proliferation, differentiation and survival. The Notch
signaling pathway is one of the most commonly activated signaling pathways in cancer …

Targeting the notch signaling pathway in chronic inflammatory diseases

PF Christopoulos, TT Gjølberg, S Krüger… - Frontiers in …, 2021 - frontiersin.org
The Notch signaling pathway regulates developmental cell-fate decisions and has recently
also been linked to inflammatory diseases. Although therapies targeting Notch signaling in …

Effects of endothelial cell proliferation and migration rates in a computational model of sprouting angiogenesis

KA Norton, AS Popel - Scientific reports, 2016 - nature.com
Angiogenesis, the recruitment of new blood vessels, is a critical process for the growth,
expansion, and metastatic dissemination of developing tumors. Three types of cells make up …

Molecular mechanisms of resistance to immunotherapy and antiangiogenic treatments in clear cell renal cell carcinoma

PÁ Ballesteros, J Chamorro, MS Román-Gil, J Pozas… - Cancers, 2021 - mdpi.com
Simple Summary Renal cell carcinoma is particularly characterized by its high
vascularization and dense immune cells infiltration. The angiogenesis blockade in …

Targeting the DLL/Notch signaling pathway in cancer: challenges and advances in clinical development

WK You, TJ Schuetz, SH Lee - Molecular cancer therapeutics, 2023 - AACR
The DLL/Notch signaling pathway plays an important role in cancer as a key driver in
maintaining cancer stemness and inducing tumor angiogenesis. Many different types of …

A mathematical model coupling tumor growth and angiogenesis

J Xu, G Vilanova, H Gomez - PloS one, 2016 - journals.plos.org
We present a mathematical model for vascular tumor growth. We use phase fields to model
cellular growth and reaction-diffusion equations for the dynamics of angiogenic factors and …